Top in ID: Long COVID in vaccinated people, J&J booster

In a recent article, Healio spoke with Ziyad Al-Aly, MD, FASN, about whether long COVID can occur in vaccinated people who experience a breakthrough infection. It was the top story in infectious disease last week.

Also, last week, Johnson & Johnson released data that support the use of its booster shot in people who previously received the single-dose regimen.

Read these and more top stories in infectious disease below:

Q&A: Can fully vaccinated people develop long COVID?

Long COVID, which the CDC defines as “new, returning, or ongoing health problems” that occur weeks after a person is infected with SARS-CoV-2, has been linked to hundreds of symptoms. Read more.

J&J booster generates ninefold increase in antibodies, company says

Johnson & Johnson said that a booster dose of its COVID-19 vaccine generated a ninefold increase in antibodies among clinical trial participants compared with levels seen 28 days after the first shot. Read more.

‘A milestone’: FDA approves Pfizer-BioNTech COVID-19 vaccine

The FDA issued its full approval of the Pfizer-BioNTech COVID-19 vaccine for people aged 16 years or older — a long-awaited decision that could have implications for vaccine mandates and uptake in the United States, experts said. Read more.

Vaccines less effective in face of delta, remain protective against serious illness

COVID-19 vaccine effectiveness declined to 66% among a cohort of health care workers after delta became the predominant SARS-CoV-2 variant, according to a report in MMWR. Read more.

Multistate Salmonella outbreak linked to Italian-style meats, CDC says

The CDC is investigating two multistate outbreaks of Salmonella infections that have been linked to consumption of Italian-style meats. Read more.